Close

Maxim Group Downgrades Tekmira Pharma (TKMR) to Hold

June 15, 2015 11:18 AM EDT Send to a Friend
Maxim Group downgraded Tekmira Pharma (NASDAQ: TKMR) from Buy to Hold with a price target of $14.00 (from $27.00).Analyst Jason ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login